The long-term objective of this developmental proposal is to determine the role of adenosine triphosphate-regulated potassium (K-ATP) channels in the antiischemic actions of chronic, modest ethanol exposure in canine models of ischemia and reperfusion injury and myocardial infarction. This and other laboratories have previously demonstrated that K-ATP channel activation reduces the extent of reversible (stunned) and irreversible (infarcted) ischemic injury during experiments using brief or prolonged periods of coronary artery occlusion and reperfusion. This laboratory has also shown that myocardial protection against ischemic injury produced by K-ATP channel activation is coupled to adenosine type 1 (A1) receptors in vivo. Recent evidence suggests that chronic, modest ethanol consumption may reduce myocardial ischemia- reperfusion injury and mimic the protective effects of ischemic preconditioning by activating A1 receptors. Whether K-ATP channels are involved in mediating this ethanol-induced myocardial protection via stimulation of A1 receptors has yet to be evaluated. Adenosine type 3 (A3) receptor activation also protects against myocardial stunning and infarction, however, whether A3 receptors are involved in ethanol-induced cardioprotection is unknown. The major hypothesis to be tested is that opening of K-ATP channels mediates the antiischemic actions of chronic, modest ethanol exposure in chronically instrumented canine models of postischemic, reperfusion injury and myocardial infarction. This problem is clinically relevant because regular ethanol drinkers are more likely to survive after myocardial infarction than non drinkers. Dogs will undergo brief (15 min to produce stunning) or prolonged (60 min to produce infarction) periods of coronary occlusion with and without pretreatment (4 to 12 weeks) with daily intravenous doses of ethanol required to produce peak plasma concentrations between 5 and 10 mM. Regional systolic and diastolic function will be evaluated using left ventricular pressure-segment length diagrams. Regional myocardial perfusion (radioactive microspheres) and myocardial oxygen consumption will be measured at selected intervals in each experiment. Myocardial infarct size will be quantified with triphenyltetrazolium histochemical staining. The results will help to clarify the mechanism of the antiischemic effects of chronic, modest ethanol exposure and will provide exciting new information about the unique role of K-ATP channels in reversible and irreversible ischemic injury.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AA012331-01
Application #
2893710
Study Section
Health Services Research Review Subcommittee (AA)
Project Start
1999-08-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Pagel, Paul S; Kehl, Franz; Gare, Meir et al. (2003) Mechanical function of the left atrium: new insights based on analysis of pressure-volume relations and Doppler echocardiography. Anesthesiology 98:975-94
Kehl, Franz; Krolikowski, John G; LaDisa Jr, John F et al. (2003) Adenosine type 1 (A1) receptors mediate protection against myocardial infarction produced by chronic, intermittent ingestion of ethanol in dogs. Int J Cardiol 88:175-82
Hettrick, Douglas A; Mittelstadt, Jacqueline R; Kehl, Franz et al. (2003) Atrial pacing lead location alters the hemodynamic effects of atrial-ventricular delay in dogs with pacing induced cardiomyopathy. Pacing Clin Electrophysiol 26:853-61
LaDisa Jr, John F; Hettrick, Douglas A; Olson, Lars E et al. (2002) Stent implantation alters coronary artery hemodynamics and wall shear stress during maximal vasodilation. J Appl Physiol 93:1939-46
Kehl, Franz; Pagel, Paul S; Krolikowski, John G et al. (2002) Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg 95:1162-8, table of contents
Tanaka, Katsuya; Kehl, Franz; Gu, Weidong et al. (2002) Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 282:H2018-23
Kehl, Franz; Krolikowski, John G; Mraovic, Boris et al. (2002) Is isoflurane-induced preconditioning dose related? Anesthesiology 96:675-80
Kehl, Franz; Kress, Tobias T; Mraovic, Boris et al. (2002) Propofol alters left atrial function evaluated with pressure-volume relations in vivo. Anesth Analg 94:1421-6, table of contents
Kehl, Franz; Krolikowski, John G; Mraovic, Boris et al. (2002) Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 96:183-8
Kehl, Franz; Krolikowski, John G; Tessmer, John P et al. (2002) Increases in coronary collateral blood flow produced by sevoflurane are mediated by calcium-activated potassium (BKCa) channels in vivo. Anesthesiology 97:725-31

Showing the most recent 10 out of 19 publications